Dopamine receptor D3 is related to prognosis in human hepatocellular carcinoma and inhibits tumor growth.
Dopamine receptor D3 is related to prognosis in human hepatocellular carcinoma and inhibits tumor growth.
复制标题
多巴胺受体 D3 与人肝细胞癌的预后相关并抑制肿瘤生长
DOI:
10.1186/s12885-022-10368-y
复制
发表时间:
2022-12-02
期刊:
影响因子:
3.8
通讯作者:
Chen, Dongtai
中科院分区:
文献类型:
--
作者:
Yan, Yan;Chen, Yonghua;Pan, Jiahao;Xing, Wei;Li, Qiang;Wang, Yan;Gei, Liba;Yuan, Yunfei;Xie, Jingdun;Zeng, Weian;Chen, Dongtai
BackgroundDopamine receptors have been reported to play important roles in cancer progression. However, the role of dopamine receptor D3 (DRD3) in hepatocellular carcinoma (HCC) remains unclear.MethodsThe expression of DRD3 was detected by immunohistochemistry and real-time qPCR. The prognostic value of DRD3 in patients was investigated by analyzing selected databases, including cBioPortal and Kaplan–Meier plotter. Cell growth was tested by CCK8 assay, and Transwell assays were performed to assess cancer cell migration and invasion. The cAMP/ERK/CREB signaling pathway was evaluated by Western blot analysis and ELISA. An HCC xenograft model was established for in vivo experiments.ResultsDRD3 mRNA expression was significantly higher in nontumor tissues than in tumor tissues. Lower protein expression of DRD3 was related to poor recurrence-free survival (RFS) and overall survival (OS). Kaplan–Meier plotter analysis showed that higher expression of DRD3 mRNA was associated with better OS, RFS, disease-specific survival (DSS), and progression-free survival (PFS). cBioPortal analysis revealed that the alteration group, which harbored genetic mutations in DRD3, exhibited poor OS, RFS, DSS and PFS. According to CCK8 and Transwell assays, stable DRD3 overexpression cell line (ex-DRD3-SK-HEP-1) showed weaker proliferation, migration and invasion behaviors. PD128907, a DRD3 agonist, suppressed proliferation, migration and invasion in HCC cell lines, while U99194, a DRD3 antagonist, enhanced proliferation, migration and invasion in HCC cell lines. Western blot analysis and ELISA revealed that stable DRD3 knock-down cell line (sh-DRD3-PLC/PRF/5) and U99194 both increased the protein levels of cAMP, p-ERK and p-CREB; on the other hand, ex-DRD3-SK-HEP-1 and PD128907 decreased the protein levels of cAMP, p-ERK and p-CREB. SCH772984, an ERK antagonist, abolished the effect of U99194 on the malignant biological behaviors of HCC cells. In vivo, PD128907 suppressed tumor growth, and U99194 enhanced tumor growth.ConclusionOur results suggest that down-regulation of DRD3 is strongly involved in the progression of HCC, and DRD3 might be consider as an independent prognostic factor for HCC. Furthermore, DRD3 agonists may be a promising strategy for HCC therapy.
登录
查看更多内容
DOI:
10.1016/s0140-6736(18)32203-7
发表时间:
2018-11-10
期刊:
Lancet (London, England)
影响因子:
--
作者:
GBD 2017 Causes of Death Collaborators
通讯作者:
GBD 2017 Causes of Death Collaborators
影响因子:
14.9
作者:
Kanehisa M;Furumichi M;Sato Y;Ishiguro-Watanabe M;Tanabe M
通讯作者:
Tanabe M
影响因子:
7.3
作者:
Gao J;Aksoy BA;Dogrusoz U;Dresdner G;Gross B;Sumer SO;Sun Y;Jacobsen A;Sinha R;Larsson E;Cerami E;Sander C;Schultz N
通讯作者:
Schultz N
影响因子:
29.4
作者:
Jandaghi, Pouria;Najafabadi, Hamed S.;Hoheisel, Joerg D.
通讯作者:
Hoheisel, Joerg D.
影响因子:
--
作者:
Eblen ST
通讯作者:
Eblen ST